title: Beta blockers: an innovation in the treatment of infantile hemangiomas.
abstract: Infantile hemangiomas are benign vascular tumors seen in 4.5 percent of neonates and infants. While most infantile hemangiomas can be managed with active nonintervention, a subset of patients will require more aggressive management. Here the authors review the use of beta-blockers in the treatment of infantile hemangiomas, including oral, topical, and multimodal treatment options. They discuss the latest data on propranolol, including criteria for patient selection, dosing recommendations, and appropriate monitoring for side effects and efficacy. Lastly, they review indications for topical timolol treatment and the potential benefits of concomitant laser therapy.
authors: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
authors: Shehla
authors: S
authors: Admani
authors: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
authors: Stephanie
authors: S
authors: Feldstein
authors: Department of Pediatrics, University of Chicago, Chicago, Illinois.
authors: Ernesto M
authors: EM
authors: Gonzalez
authors: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital-San Diego and University of California at San Diego School of Medicine, San Diego, California;
authors: Sheila Fallon
authors: SF
authors: Friedlander